Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1153.7000 15.10 (1.33%)
NSE Jul 15, 2025 13:30 PM
Volume: 511.0K
 

1153.70
1.33%
Sharekhan
Quarterly revenue reached Rs. 7,796 crore, up 8% y-o-y and 3% q-o-q, exceeding our estimates by 1%, while PAT was Rs. 817 crore, showing a 9% y-o-y increase but an 11% q-o-q decrease, falling 19% below our estimates.
Geojit BNP Paribas decreased Buy price target of Aurobindo Pharma Ltd. to 1348.0 on 04 Jul, 2025.
More from Aurobindo Pharma …
All earning calls
Investor presentations from Aurobindo Pharma …
All investor presentations